Abstract
Recombinant therapeutic proteins have been considered as an efficient category of medications used for the treatment of various diseases. Despite their effectiveness, there are some reports on the systemic adverse effects of recombinant therapeutic proteins limiting their wide clinical applications. Among different cytokines used for cancer immunotherapy, interleukin-12 (IL-12) has shown great ability as a powerful antitumor and antiangiogenic agent. However, significant toxic reactions following the systemic administration of IL-12 have led researchers to seek for alternative approaches such as the delivery and local expression of the IL-12 gene inside the tumor tissues. In order to transfer the plasmid encoding IL-12 gene, the most extensively investigated polycationic polymer, polyethylenimine (PEI), was modified by diethylene triamine penta-acetic acid (DTPA) to modulate the hydrophobic-hydrophilic balance of the polymer as well as its toxicity. DTPA-conjugated PEI derivatives were able to form complexes in the size range around 100–180 nm with great condensation ability and protection of the plasmid against enzymatic degradation. The highest gene transfer ability was achieved by the DTPA-conjugated PEI at the conjugation degree of 0.1 % where the level of IL-12 production increased up to twofold compared with that of the unmodified PEI. Results of the present study demonstrated that modulation of the surface positive charge of PEI along with the improvement of the polymer hydrophobic balance could be considered as a successful strategy to develop safe and powerful nanocarriers.
Similar content being viewed by others
References
Kamimura, K., Suda, T., Zhang, G., & Liu, D. (2011). Advances in gene delivery systems. Pharmaceutical Medicine, 25, 293–306.
Clarke, D. T., & McMillan, N. A. (2014). Gene delivery: cell-specific therapy on target. Nature Nanotechnology, 9, 568–569.
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009). Knocking down barriers: advances in siRNA delivery. Nature Reviews Drug Discovery, 8, 129–138.
Kotterman, M. A., & Schaffer, D. V. (2014). Engineering adeno-associated viruses for clinical gene therapy. Nature Reviews Genetics, 15, 445–451.
Gore, M. (2003). Gene therapy can cause leukaemia: no shock, mild horror but a probe. Gene Therapy, 10, 4–4.
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014). Non-viral vectors for gene-based therapy. Nature Reviews Genetics, 15, 541–555.
Gansbacher, B. (2003). Report of a second serious adverse event in a clinical trial of gene therapy for X‐linked severe combined immune deficiency (X‐SCID). The Journal of Gene Medicine, 5, 261–262.
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005). Design and development of polymer for gene delivery. Nature Reviews Drug Discovery, 4, 581–593.
Thomas, M., & Klibanov, A. (2003). Non-viral gene therapy: polycation-mediated DNA delivery. Applied Microbiology and Biotechnology, 62, 27–34.
Lehrman, S. (1999). Virus treatment questioned after gene therapy death. Nature, 401, 517–518.
Dehshahri, A., & Sadeghpour, H. (2015). Surface decorations of poly (amidoamine) dendrimer by various pendant moieties for improved delivery of nucleic acid materials. Colloids and Surfaces B: Biointerfaces, 132, 85–102.
Wagner, E., & Lächelt, U. (2015). Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond). Chemical Reviews, 115, 11043–11078.
Behr, J.-P., Boussif, O., Lezoualc’h, F., Zanta, M. A., Mergny, M. D., Scherman, D., & Demeneix, B. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proceedings of the National Academy of Sciences, 92, 7297–7301.
Wiethoff, C. M., GillI, M., Koe, G. S., Koe, J. G., & Middaugh, C. R. (2003). A fluorescence study of the structure and accessibility of plasmid DNA condensed with cationic gene delivery vehicles. Journal of Pharmaceutical Sciences, 92, 1272–1285.
Cho, Y. W., Kim, J. D., & Park, K. (2003). Polycation gene delivery systems: escape from endosomes to cytosol. Journal of Pharmacy and Pharmacology, 55, 721–734.
Dehshahri, A., Oskuee, R. K., Shier, W. T., Hatefi, A., & Ramezani, M. (2009). Gene transfer efficiency of high primary amine content, hydrophobic, alkyl-oligoamine derivatives of polyethylenimine. Biomaterials, 30, 4187–4194.
Petersen, H., Fechner, P. M., Martin, A. L., Kunath, K., Stolnik, S., Roberts, C. J., Fischer, D., Davies, M. C., & Kissel, T. (2002). Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chemistry, 13, 845–854.
Zintchenko, A., Philipp, A., Dehshahri, A., & Wagner, E. (2008). Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjugate Chemistry, 19, 1448–1455.
Klibanov, A. M., & Thomas, M. (2002). Enhancing polyethylenimine’s delivery of plasmid DNA into mammalian cells. Proceedings of the National Academy of Sciences, 99, 14640–14645.
Dehshahri, A., Kazemi Oskuee, R., Thomas Shier, W., & Ramezani, M. (2012). β-Galactosylated alkyl-oligoamine derivatives of polyethylenimine enhanced pDNA delivery into hepatic cells with reduced toxicity. Current Nanoscience, 8, 548–555.
Dehshahri, A., Oskuee, R. K., & Ramezani, M. (2012). Plasmid DNA delivery into hepatocytes using a multifunctional nanocarrier based on sugar-conjugated polyethylenimine. Gene Therapy and Molecular Biology, 14, 62–71.
Oskuee, R. K., Dehshahri, A., Shier, W. T., & Ramezani, M. (2009). Alkylcarboxylate grafting to polyethylenimine: a simple approach to producing a DNA nanocarrier with low toxicity. The Journal of Gene Medicine, 11, 921–932.
Oskuee, R. K., Philipp, A., Dehshahri, A., Wagner, E., & Ramezani, M. (2010). The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery. The Journal of Gene Medicine, 12, 729–738.
Liang, W., Gong, H., Yin, D., Lu, S., & Fu, Q. (2011). High-molecular-weight polyethyleneimine conjuncted pluronic for gene transfer agents. Chemical and Pharmaceutical Bulletin, 59, 1094–1101.
Doody, A. M., Korley, J. N., Dang, K. P., Zawaneh, P. N., & Putnam, D. (2006). Characterizing the structure/function parameter space of hydrocarbon-conjugated branched polyethylenimine for DNA delivery in vitro. Journal of Controlled Release, 116, 227–237.
Choi, K. J., Zhang, S. N., Choi, I. K., Kim, J. S., & Yun, C.-O. (2012). Strengthening of sntitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF. Gene Therapy, 19, 711–723.
Colombo, M. P., & Trinchieri, G. (2002). Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Review, 13, 155–168.
Chinnasamy, D., Yu, Z., Kerkar, S. P., Zhang, L., Morgan, R. A., Restifo, N. P., & Rosenberg, S. A. (2012). Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice. Clinical Cancer Research, 18, 1672–1683.
Xu, Q., Guo, L., Gu, X., Zhang, B., Hu, X., Zhang, J., Chen, J., Wang, Y., Chen, C., & Gao, B. (2012). Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12. Biomaterials, 33, 3909–3918.
Mahato, R. I., Lee, M., Han, S., Maheshwari, A., & Kim, S. W. (2001). Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. Molecular Therapy, 4, 130–138.
Janát-Amsbury, M. M., Yockman, J. W., Lee, M., Kern, S., Furgeson, D. Y., Bikram, M., & Kim, S. W. (2004). Combination of local, nonviral IL-12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Molecular Therapy, 9, 829–836.
Janát-Amsbury, M. M., Yockman, J. W., Lee, M., Kern, S., Furgeson, D. Y., Bikram, M., & Kim, S. W. (2005). Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment. Journal of Controlled Release, 101, 273–285.
Snyder, S. L., & Sobocinski, P. Z. (1975). An improved 2, 4, 6-trinitrobenzenesulfonic acid method for the determination of amines. Analytical Biochemistry, 64, 284–288.
Tang, M., & Szoka, F. (1997). The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Therapy, 4, 823–832.
Ward, W. S., & Coffey, D. (1991). DNA packaging and organization in mammalian spermatozoa: comparison with somatic cells. Biology of Reproduction, 44, 569–574.
Iacomino, G., Picariello, G., & D’Agostino, L. (2012). DNA and nuclear aggregates of polyamines. Biochimica et Biophysica Acta (BBA)-Molecular. Cell Research, 1823, 1745–1755.
Hardy, J. G., Kostiainen, M. A., Smith, D. K., Gabrielson, N. P., & Pack, D. W. (2006). Dendrons with spermine surface groups as potential building blocks for nonviral vectors in gene therapy. Bioconjugate Chemistry, 17, 172–178.
Chen, W., Turro, N. J., & Tomalia, D. A. (2000). Using ethidium bromide to probe the interactions between DNA and dendrimers. Langmuir, 16, 15–19.
Ottaviani, M. F., Furini, F., Casini, A., Turro, N. J., Jockusch, S., Tomalia, D. A., & Messori, L. (2000). Formation of supramolecular structures between DNA and starburst dendrimers studied by EPR, CD, UV, and melting profiles. Macromolecules, 33, 7842–7851.
Dehshahri, A., Sadeghpour, H., Oskuee, R. K., Fadaei, M., Sabahi, Z., Alhashemi, S. H., & Mohazabieh, E. (2014). Interleukin-12 plasmid DNA delivery using l-thyroxine-conjugated polyethylenimine nanocarriers. Journal of Nanoparticle Research, 16, 1–14.
Forrest, M. L., Meister, G. E., Koerber, J. T., & Pack, D. W. (2004). Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharmaceutical Research, 21, 365–371.
Gabrielson, N. P., & Pack, D. W. (2006). Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules, 7, 2427–2435.
Nimesh, S., Aggarwal, A., Kumar, P., Singh, Y., Gupta, K. C., & Chandra, R. (2007). Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles. International Journal of Pharmaceutics, 337, 265–274.
Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R., & Wagner, E. (1998). The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Therapy, 5, 1425–1433.
Sabahi, Z., Samani, S. M., & Dehshahri, A. (2015). Conjugation of poly (amidoamine) dendrimers with various acrylates for improved delivery of plasmid encoding interleukin-12 gene. Journal of Biomaterials Applications, 29, 941–953.
Dehshahri, A., Alhashemi, S. H., Jamshidzadeh, A., Sabahi, Z., Samani, S. M., Sadeghpour, H., Mohazabieh, E., & Fadaei, M. (2013). Comparison of the effectiveness of polyethylenimine, polyamidoamine and chitosan in transferring plasmid encoding interleukin-12 gene into hepatocytes. Macromolecular Research, 21, 1322–1330.
Behr, J.-P. (1997). The proton sponge: a trick to enter cells the viruses did not exploit. CHIMIA International Journal for Chemistry, 51, 34–36.
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005). Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis. The Journal of Gene Medicine, 7, 657–663.
Tseng, W. C., Tang, C. H., & Fang, T. Y. (2004). The role of dextran conjugation in transfection mediated by dextran-grafted polyethylenimine. The Journal of Gene Medicine, 6, 895–905.
Ihm, J. E., Krier, I., Lim, J. M., Shim, S., Han, D. K., & Hubbell, J. A. (2015). Improved biocompatibility of polyethylenimine (PEI) as a gene carrier by conjugating urocanic acid: in vitro and in vivo. Macromolecular Research, 23, 387–395.
Salmasi, Z., Shier, W. T., Hashemi, M., Mahdipour, E., Parhiz, H., Abnous, K., & Ramezani, M. (2015). Heterocyclic amine-modified polyethylenimine as gene carriers for transfection of mammalian cells. European Journal of Pharmaceutics and Biopharmaceutics, 96, 76–88.
Mahvi, D., Henry, M., Albertini, M., Weber, S., Meredith, K., Schalch, H., Rakhmilevich, A., Hank, J., & Sondel, P. (2007). Intratumoral injection of IL-12 plasmid DNA—results of a phase I/IB clinical trial. Cancer Gene Therapy, 14, 717–723.
Anwer, K., Barnes, M., Fewell, J., Lewis, D., & Alvarez, R. (2010). Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer. Gene Therapy, 17, 360–369.
Sangro, B., Mazzolini, G., Ruiz, J., Herraiz, M., Quiroga, J., Herrero, I., Benito, A., Larrache, J., Pueyo, J., & Subtil, J. C. (2004). Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. Journal of clinical oncology, 22, 1389–1397.
Younes, A., Pro, B., Robertson, M. J., Flinn, I. W., Romaguera, J. E., Hagemeister, F., Dang, N. H., Fiumara, P., Loyer, E. M., & Cabanillas, F. F. (2004). Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin’s lymphoma and Hodgkin’s disease. Clinical Cancer Research, 10, 5432–5438.
Cohen, J. (1995). IL-12 deaths: explanation and a puzzle. Science, 270, 908–908.
Ozmen, L., Pericin, M., Hakimi, J., Chizzonite, R. A., Wysocka, M., Trinchieri, G. a., Gately, M., & Garotta, G. (1994). Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. The Journal of Experimental Medicine, 180, 907–915.
Hallaj-Nezhadi, S., Lotfipour, F., & Dass, C. (2011). Nanoparticle-mediated interleukin-12 cancer gene therapy. Journal of Pharmacy Pharmaceutical Sciences, 13, 472–485.
Oskuee, R., Dehshahri, A., Ramezani, M., & Shier, W. (2008). Modified polyethylenimine: self assemble nanoparticle forming polymer for pDNA delivery. Iranian Journal of Basic Medical Sciences, 11, 33–40.
Hashemi, M., Ayatollahi, S., Parhiz, H., Mokhtarzadeh, A., Javidi, S., & Ramezani, M. (2015). PEGylation of polypropylenimine dendrimer with alkylcarboxylate chain linkage to improve DNA delivery and cytotoxicity. Applied Biochemistry and Biotechnology, 177, 1–17.
Li, G. F., Wang, J. C., Feng, X. M., Liu, Z. D., Jiang, C. Y., & Yang, J. D. (2015). Preparation and testing of quaternized chitosan nanoparticles as gene delivery vehicles. Applied Biochemistry and Biotechnology, 175, 3244–3257.
Acknowledgments
This study was funded by Shiraz University of Medical Sciences, Shiraz, Iran. The financial support by the Iranian Nanotechnology Initiative Council (INIC) is gratefully acknowledged. The results presented in this paper were parts of the Pharm.D. thesis of Maryam Keykhaee. We would like to thank Dr Shiva Hemmati and Dr. Samira Hossaini Alhashemi for their helpful assistances.
Funding
This study was funded by Shiraz University of Medical Sciences, Shiraz, Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Dehshahri, A., Sadeghpour, H., Keykhaee, M. et al. Enhanced Delivery of Plasmid Encoding Interleukin-12 Gene by Diethylene Triamine Penta-Acetic Acid (DTPA)-Conjugated PEI Nanoparticles. Appl Biochem Biotechnol 179, 251–269 (2016). https://doi.org/10.1007/s12010-016-1991-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-016-1991-1